Speed to the Clinic, Without Compromise.Catalent's GPEx® Lightning Cell Line Development Platform delivers unmatched efficiency, stability, and yield.Learn More CATALENT LAUNCHES UPTEMPO℠ CAR-T CELL THERAPY PLATFORM, A FULLY CLOSED GMP-COMPLIANT WORKFLOWLearn More CATALENT EXPANDS UPTEMPO℠ AAV PLATFORM TO ACCELERATE DEVELOPMENT OF GENE THERAPIESLearn More BIOLOGICS CDMOCreate better biologic treatments and speed your path to market with our range of advanced technologies and services.Learn More How can we work together BIOLOGICS GENE THERAPY CELL THERAPY TECHNOLOGIES Latest News Catalent Announces Collaboration with Galapagos to Further Expand Galapagos’ Decentralized CAR-T Manufacturing Network in the U.S. CELL THERAPY Catalent enables fully integrated cell therapy services, from iPSC differentiation, development, and manufacturing expertise, to process and analytical development across cell types, to clinical and commercial manufacturing in the United States and Europe. UPTEMPO℠ AAV PLATFORM PROCESS A scalable, cGMP-ready process providing early-stage partners with accelerated timelines for production of their clinical material FORMULATION DEVELOPMENT The formulation scientists at Catalent Biologics have experience in a variety of formulations and product presentations to help you develop and deliver your clinical or commercial formulation, faster. BIOLOGICS ANALYTICAL METHODS: TRENDS AND STRATEGIES TO ACCELERATE BIOLOGICS DEVELOPMENT In this webinar, experts describe how the stepwise approach for bioanalytical testing can be used to reduce risks and challenges present in biologics development. BIOLOGICS NETWORK Our network of biologics sites provides an integrated approach to get medicines to your patients faster anywhere in the world. LEARN MORE JOIN OUR TEAM Catalent is growing in Biologics and is making significant investments in people in this area. Explore global career opportunities with our Biologics team. NEWS Silexion Therapeutics Announces Collaboration with Global Therapeutics Leader Catalent on Advanced siRNA Formulation Development & Clinical Manufacturing Activities Catalent Announces Collaboration with Galapagos to Further Expand Galapagos’ Decentralized CAR-T Manufacturing Network in the U.S. IsomAb Announces Strategic Collaboration with Catalent Siren Biotechnology and Catalent Enter Partnership for Manufacturing of AAV Gene Therapies for Cancer VIEW ALL NEWS VIEW ALL EVENTS EXPERT CONTENT UpTempo(SM) Plasmid Platform Seamless Transitions from Bench to CGT Applications Proven Expertise for Biologics Development, Manufacturing & Delivery with Capacity for Small Commercial Volume Leveraging Advanced Technology & Proven Expertise from Cell Line Development & Beyond The Critical Role of Forced Degradation in Method Development, Manufacturability & CMC Strategy VIEW ALL ARTICLES
